Blast Crisis - 24 Studies Found Completed : An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis : Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis : 2005-09-12 : Drug: imatinib mesylate Other Name: Gleevec/Glivec Completed : Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate : Chronic Myeloid Leukemia Blast Crisis : 2005-01-13 : Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, Until disease progression or intolerable toxicity, sw Terminated : Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia : Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous : 2001-09-13 : Biological: bevacizumab Given Completed : An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Leukemia, Myeloid, Chronic : 2007-10-01 : Drug: Glivec®/Gleevec® Chemotherapy Completed : STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis : Leukemia : 2000-11-06 : Drug: imatinib mesylate No longer available : Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant : Chronic Myelogenous Leukemia : 2006-12-18 : Drug: nilotinib Approved for marketing : Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Chronic Myeloid Leukemia : 2009-05-18 : Drug: Nilotinib Completed : Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis) : Leukemia, Myeloid, Chronic : 2007-03-20 : Drug: panobinostat LBH589 Completed : A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Chronic Myeloid Leukemia : 2010-05-18 : Drug: Nilotinib Completed : Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Chronic Myeloid Leukemia : 2008-11-05 : Drug: Nilotinib Next >>>
